1. Home
  2. NIU vs RLMD Comparison

NIU vs RLMD Comparison

Compare NIU & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Niu Technologies

NIU

Niu Technologies

HOLD

Current Price

$3.24

Market Cap

275.6M

ML Signal

HOLD

Logo Relmada Therapeutics Inc.

RLMD

Relmada Therapeutics Inc.

HOLD

Current Price

$4.50

Market Cap

319.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NIU
RLMD
Founded
2014
2004
Country
China
United States
Employees
N/A
N/A
Industry
Auto Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
275.6M
319.0M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
NIU
RLMD
Price
$3.24
$4.50
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$9.50
AVG Volume (30 Days)
721.5K
1.0M
Earning Date
11-17-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$625,182,280.00
N/A
Revenue This Year
$42.51
N/A
Revenue Next Year
$23.71
N/A
P/E Ratio
N/A
N/A
Revenue Growth
50.99
N/A
52 Week Low
$1.66
$0.24
52 Week High
$5.67
$5.12

Technical Indicators

Market Signals
Indicator
NIU
RLMD
Relative Strength Index (RSI) 43.97 58.07
Support Level $2.89 $4.28
Resistance Level $3.40 $4.75
Average True Range (ATR) 0.17 0.37
MACD 0.05 -0.03
Stochastic Oscillator 64.36 58.02

Price Performance

Historical Comparison
NIU
RLMD

About NIU Niu Technologies

Niu Technologies designs, manufactures and sells high-performance electric motorcycles, scooters, bicycles, and kick-scooters. The company has a product portfolio consisting of electric motorcycle, mopeds and bicycle series, including the NQi, MQi, UQi, F series, and others, and micro-mobility series, including the kick-scooter series KQi and the e-bike series BQi. The company's principal operations and geographic markets are predominantly in the People's Republic of China. It also generates revenue from Europe and other regions.

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

Share on Social Networks: